ScholarIQanswers from OpenAlex

Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy

PaperCitations, authors & open-access status

Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy have?

ScholarIQcitation count

Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy has 29 citations in the OpenAlex counts ScholarIQ stores.

When was Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy published?

ScholarIQyear

Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy has 2017 year in the ScholarIQ index.

What is the open-access status of Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy?

ScholarIQoa status

Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy has hybrid oa status in the ScholarIQ index.

What is the DOI of Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy?

ScholarIQdoi

The DOI for Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy is on the source record.

What is the PMID of Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy?

ScholarIQpmid

The PMID for Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy is on the source record.

What is the OpenAlex record for Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy?

ScholarIQopenalex

The OpenAlex for Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial